Indonesia is delaying the rollout of a COVID-19 vaccine manufactured by British-Swedish pharmaceutical company AstraZeneca pending a review by the World Health Organization (WHO) into concerns about blood clots, a move that experts say could affect its ambitious vaccination targets.
The Food and Drug Monitoring Agency (BPOM) is liaising with the WHO and the Strategic Advisory Group of Experts on Immunization (SAGE) to decide whether to use the AstraZeneca vaccine in the government’s mass vaccination program.
“Hopefully, [we will have clarity] soon, because the vaccines [we have already received] have an expiration date of late May,” Health Minister Budi Gunadi Sadikin told lawmakers at a hearing on Monday.
Indonesia joins Denmark, Norway, Ireland, the Netherlands and other countries that have also suspended usage of the AstraZeneca jab i...
Starting from IDR 55,000/month